1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Radiation Oncology Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Radiation Oncology Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Radiation Oncology Market Regional Analysis
6.2 North America Radiation Oncology Market Revenue 2021-2031 (US$ Million)
6.3 North America Radiation Oncology Market Forecast Analysis
7. North America Radiation Oncology Market Analysis – by Types
7.1 External Beam Radiation Therapy
- 7.1.1 Overview
- 7.1.2 External Beam Radiation Therapy: North America Radiation Oncology Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Internal Beam Radiation Therapy
- 7.2.1 Overview
- 7.2.2 Internal Beam Radiation Therapy: North America Radiation Oncology Market – Revenue and Forecast, 2021-2031 (US$ Million)
8. North America Radiation Oncology Market Analysis – by Application
8.1 Breast Cancer
- 8.1.1 Overview
- 8.1.2 Breast Cancer: North America Radiation Oncology Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Prostate Cancer
- 8.2.1 Overview
- 8.2.2 Prostate Cancer: North America Radiation Oncology Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Lung Cancer
- 8.3.1 Overview
- 8.3.2 Lung Cancer: North America Radiation Oncology Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.4 Head & Neck Cancer
- 8.4.1 Overview
- 8.4.2 Head & Neck Cancer: North America Radiation Oncology Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.5 Cervical Cancer
- 8.5.1 Overview
- 8.5.2 Cervical Cancer: North America Radiation Oncology Market – Revenue and Forecast, 2021-2031 (US$ Million)
9. North America Radiation Oncology Market – North America Analysis
9.1 Overview
9.2 North America
- 9.2.1 North America Radiation Oncology Market Breakdown, by Key
Country, 2024 and 2031 (%)
- 9.2.1.1 North America Radiation Oncology Market – Revenue and
Forecast Analysis – by Country
- 9.2.1.1 US:
North America Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
- 9.2.1.1.1 US: North America Radiation Oncology Market Breakdown, by Types
- 9.2.1.1.2 US: North America Radiation Oncology Market Breakdown, by Application
- 9.2.1.2 Canada:
North America Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
- 9.2.1.2.1 Canada: North America Radiation Oncology Market Breakdown, by Types
- 9.2.1.2.2 Canada: North America Radiation Oncology Market Breakdown, by Application
- 9.2.1.3 Mexico :
North America Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
- 9.2.1.3.1 Mexico : North America Radiation Oncology Market Breakdown, by Types
- 9.2.1.3.2 Mexico : North America Radiation Oncology Market Breakdown, by Application
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. Industry Landscape
11.1 Overview
11.2 Market Initiative
11.3 Partnerships and Collaborations
11.4 Other Developments
12. Company Profiles
12.1 Varian Medical Systems Inc.
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Elekta AB.
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Accuray Incorporated.
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 IBA Worldwide (Ion Beam Applications SA).
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Becton Dickinson and Co.
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Perspective Therapeutics Inc.
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 NTP RADIOISOTOPES.
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Mallinckrodt Plc.
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Provision Healthcare.
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Curium.
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
13. Appendix
13.1 About Business Market Insights
13.2 List of Abbreviations